The 'complexities' of life and death: death receptor signalling platforms.

Cell death is critical to the normal functioning of multi-cellular organisms, playing a central role in development, immunity, inflammation, and cancer progression. Two cell death mechanisms, apoptosis and necroptosis, are dependent on the formation of distinct multi-protein complexes including the DISC, Apoptosome, Piddosome and Necrosome following the induction of cell death by specific stimuli. The role of several of these key multi-protein signalling platforms, namely the DISC, TNFR1 complex I/II, the Necrosome and Ripoptosome, in mediating these pathways will be discussed, as well as the open questions and potential therapeutic benefits of understanding their underlying mechanisms.

[1]  D. Green,et al.  A unified model for apical caspase activation. , 2003, Molecular cell.

[2]  J. Tschopp,et al.  The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[3]  Liwei Wang,et al.  The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutations , 2010, Nature Structural &Molecular Biology.

[4]  D. Lawrence,et al.  Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling , 2009, Cell.

[5]  M. Peter,et al.  Programmed cell death: Apoptosis meets necrosis , 2011, Nature.

[6]  M. Butterworth,et al.  Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. , 2009, Molecular cell.

[7]  Xiaodong Wang,et al.  TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.

[8]  J. Grotta,et al.  Necroptosis, a novel form of caspase‐independent cell death, contributes to neuronal damage in a retinal ischemia‐reperfusion injury model , 2009, Journal of neuroscience research.

[9]  G. Cohen,et al.  TRAIL signals to apoptosis in CLL cells primarily through TRAIL R-1 whereas cross-linked agonistic TRAIL R-2 antibodies facilitate signalling via TRAIL R-2 , 2007 .

[10]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[11]  V. Dixit,et al.  Identification of a Novel Homotypic Interaction Motif Required for the Phosphorylation of Receptor-interacting Protein (RIP) by RIP3* , 2002, The Journal of Biological Chemistry.

[12]  D. Yellon,et al.  Necrostatin: A Potentially Novel Cardioprotective Agent? , 2007, Cardiovascular Drugs and Therapy.

[13]  J. Tschopp,et al.  The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.

[14]  G. Superti-Furga,et al.  Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression , 2006, The EMBO journal.

[15]  Karen Billeci,et al.  Receptor-selective Mutants of Apoptosis-inducing Ligand 2/Tumor Necrosis Factor-related Apoptosis-inducing Ligand Reveal a Greater Contribution of Death Receptor (DR) 5 than DR4 to Apoptosis Signaling* , 2005, Journal of Biological Chemistry.

[16]  G. Cohen,et al.  TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL‐R1 whereas cross‐linked agonistic TRAIL‐R2 antibodies facilitate signalling via TRAIL‐R2 , 2007, British journal of haematology.

[17]  L. Zitvogel,et al.  Immunogenic cell death modalities and their impact on cancer treatment , 2009, Apoptosis.

[18]  G. Cohen,et al.  Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[19]  W. Kaiser,et al.  Virus inhibition of RIP3-dependent necrosis. , 2010, Cell Host and Microbe.

[20]  P. Krammer,et al.  c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[21]  Boguslaw Stec,et al.  The Fas/FADD death domain complex structure unravels signaling by receptor clustering , 2008, Nature.

[22]  M. Komatsu,et al.  Mechanisms of necroptosis in T cells , 2011, The Journal of experimental medicine.

[23]  Liwei Wang,et al.  Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition. , 2006, Molecular cell.

[24]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[25]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[26]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[27]  H. Gollnick,et al.  Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95- and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex* , 2011, The Journal of Biological Chemistry.

[28]  Serge Batalov,et al.  Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. , 2003, Molecular cell.

[29]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[30]  M. H. Werner,et al.  The structure of FADD and its mode of interaction with procaspase-8. , 2006, Molecular cell.

[31]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[32]  G. Salvesen,et al.  Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity , 2011, Proceedings of the National Academy of Sciences.

[33]  P. Krammer,et al.  Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex* , 2001, The Journal of Biological Chemistry.

[34]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[35]  G. Cavet,et al.  Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL , 2007, Nature Medicine.

[36]  S. Yonehara,et al.  Requirement of cooperative functions of two repeated death effector domains in caspase‐8 and in MC159 for induction and inhibition of apoptosis, respectively , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[37]  M. H. Werner,et al.  FADD self-association is required for stable interaction with an activated death receptor , 2006, Cell Death and Differentiation.

[38]  G. Cohen,et al.  TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. , 2005, Cancer research.

[39]  Fiona C. Kimberley,et al.  Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease. , 2011, Trends in molecular medicine.

[40]  Daniel R. Beisner,et al.  Antigen-mediated T cell expansion regulated by parallel pathways of death , 2008, Proceedings of the National Academy of Sciences.

[41]  Guy S. Salvesen,et al.  Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis , 2011, Nature.

[42]  G. Cohen,et al.  Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical Caspases* , 2001, The Journal of Biological Chemistry.

[43]  F. Chan,et al.  Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.

[44]  Vanesa Fernández-Majada,et al.  FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation , 2011, Nature.

[45]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[46]  N. Morrissette,et al.  FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells , 2008, Proceedings of the National Academy of Sciences.

[47]  David Baltimore,et al.  Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. , 2011, Molecular cell.

[48]  G. Häcker,et al.  cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms , 2011, Molecular cell.

[49]  D. Kabelitz,et al.  Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. , 2004, Immunity.

[50]  J. Tschopp,et al.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.

[51]  Brian Seed,et al.  Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.

[52]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[53]  D. Lawrence,et al.  Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand* , 2005, Journal of Biological Chemistry.

[54]  R. Xavier,et al.  CASPASE 8 inhibits programmed necrosis by processing CYLD , 2011, Nature Cell Biology.

[55]  R. Eils,et al.  Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL , 2010, The Journal of cell biology.

[56]  P. Scheurich,et al.  Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative , 2001, Oncogene.

[57]  R. Knight,et al.  Necroptosis , 2012, JAK-STAT.

[58]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[59]  Alexei Degterev,et al.  Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway , 2008, Cell.

[60]  D. Green,et al.  Inducible Dimerization and Inducible Cleavage Reveal a Requirement for Both Processes in Caspase-8 Activation* , 2010, The Journal of Biological Chemistry.

[61]  M. Ermolaeva,et al.  The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. , 2011, Immunity.

[62]  Helmut Neumann,et al.  Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis , 2011, Nature.

[63]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[64]  T. Vanden Berghe,et al.  Many stimuli pull the necrotic trigger, an overview , 2011, Cell Death and Differentiation.

[65]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[66]  C. Briand,et al.  Insights into the regulatory mechanism for caspase-8 activation. , 2003, Molecular cell.

[67]  C. Robinson,et al.  Solution NMR investigation of the CD95/FADD homotypic death domain complex suggests lack of engagement of the CD95 C terminus. , 2010, Structure.

[68]  P. Krammer,et al.  CD95 Stimulation Results in the Formation of a Novel Death Effector Domain Protein-containing Complex* , 2008, Journal of Biological Chemistry.

[69]  D. Lawrence,et al.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.

[70]  Vishva M. Dixit,et al.  Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death , 2011, Nature Reviews Molecular Cell Biology.

[71]  Na Zhang,et al.  RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis , 2009, Science.

[72]  T. Kang,et al.  Mutation of a Self-Processing Site in Caspase-8 Compromises Its Apoptotic but Not Its Nonapoptotic Functions in Bacterial Artificial Chromosome-Transgenic Mice1 , 2008, The Journal of Immunology.

[73]  M. Grütter,et al.  Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. , 2009, Structure.

[74]  T. Tenev,et al.  The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. , 2011, Molecular cell.